Clinical Trials Logo

Aceruloplasminemia clinical trials

View clinical trials related to Aceruloplasminemia.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05522374 Recruiting - Clinical trials for Neurodegeneration With Brain Iron Accumulation (NBIA)

TIRCON International NBIA Registry

TIRCON
Start date: June 14, 2012
Phase:
Study type: Observational [Patient Registry]

TIRCON-reg aims to - continue the provision of a global registry and natural history study for NBIA disorders - harmonize and cover existing national and single site registries - enable participation of countries and single sites that so far have no access to an NBIA registry - join forces in order to recruit sufficient numbers of patients - define the natural history of NBIA disorders - define the most appropriate outcome measures - inform the design and facilitate the conduction of clinical trials

NCT ID: NCT04184453 Recruiting - Aceruloplasminemia Clinical Trials

Clinical Curative Effect Evaluation Study of Treatment of Oral Deferiprone Tablets in Aceruloplasminaemia Patients

Start date: December 23, 2019
Phase: Early Phase 1
Study type: Interventional

Aceruloplasminemia is an autosomal recessive disorder characterized by iron deposition in the brain and visceral organs. Deferiprone was used to treat aceruloplasminemia in previous study. In this study, we will assess the clinical curative effect evaluation of oral deferiprone in Chinese aceruloplasminemia patients.